Biofrontera
BFRI
16 hedge funds and large institutions have $520K invested in Biofrontera in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
0.01% more ownership
Funds ownership: 0.15% → 0.16% (+0.01%)
29% less capital invested
Capital invested by funds: $729K → $520K (-$209K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$13.9K |
| 2 |
Renaissance Technologies
New York
|
+$12.3K |
| 3 |
BlackRock
New York
|
+$9.22K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.97K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$10.1K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.18K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$32 |
BFRI Hedge Fund Activity: Q1 2023 in Review
16 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2023, worth a combined $520K — down 29% from $729K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BFRI positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Mesirow Financial Investment Management, opening a new position worth an estimated $13.9K. The largest seller was Jane Street, exiting entirely with an estimated $10.1K sold.
- 16 institutional investors held Biofrontera (BFRI) as of Q1 2023, up from 14 in Q4 2022.
- Funds reported $520K of Biofrontera stock for Q1 2023, down 29% quarter-over-quarter.
- 4 funds opened new Biofrontera positions in Q1 2023 and 2 closed out, a net change of +2 holders.
- The largest Biofrontera buyer in Q1 2023 was Mesirow Financial Investment Management, an estimated $13.9K added.
- The largest Biofrontera seller in Q1 2023 was Jane Street, an estimated $10.1K sold.
Based on aggregated 13F filings for Q1 2023.